Enoxaparin Dosing for Patients on Warfarin Undergoing Surgery
Enoxaparin dosing for patients on warfarin undergoing surgery should be stratified based on the patient's thromboembolism risk, with prophylactic doses (3000 U SC q12h) for moderate-risk patients and therapeutic doses (100 U/kg SC q12h) for high-risk patients.
Risk Stratification and Perioperative Management
Pre-operative Management
- Stop warfarin 4-5 days before surgery to allow INR to return to normal (≤1.2) 1
- Consider vitamin K 2.5 mg orally 2 days before procedure to reduce the period off anticoagulation 1
- Begin bridging with enoxaparin based on thromboembolism risk 1
Enoxaparin Dosing by Risk Category
Low Thromboembolism Risk (e.g., atrial fibrillation)
- No bridging needed; simply stop warfarin 4-5 days before surgery 1
- Resume warfarin postoperatively at maintenance dose 1
- If necessary, supplement with low-dose enoxaparin (40 mg SC daily) postoperatively 1
Moderate Thromboembolism Risk
- Preoperative: Enoxaparin 3000 U (prophylactic dose) SC every 12 hours 1
- Discontinue enoxaparin 24 hours before surgery 1
- Postoperative: Restart enoxaparin at prophylactic dose 12 hours after surgery 1
- Resume warfarin simultaneously and continue both until INR returns to therapeutic range (4-5 days) 1
- If high bleeding risk postoperatively, delay enoxaparin for 24 hours or longer 1
High Thromboembolism Risk
- Preoperative: Enoxaparin 100 U/kg (therapeutic dose) SC every 12 hours 1
- Discontinue enoxaparin 24 hours before surgery 1
- Postoperative: Restart enoxaparin at prophylactic dose 12 hours after surgery 1
- Resume warfarin simultaneously and continue both until INR returns to therapeutic range 1
- For critical cases requiring continuous anticoagulation: Consider inpatient admission with IV heparin (1300 U/h) stopped 5 hours before surgery 1
Special Considerations
Timing of Postoperative Enoxaparin
- For minor procedures: Resume full therapeutic dose within 24 hours 1
- For major procedures or high bleeding risk: Wait 48-72 hours before resuming full-dose enoxaparin 1
- Consider intermediate-dose enoxaparin regimens (half-therapeutic dose of 1 mg/kg daily) which have shown favorable safety and efficacy profiles 1, 2
Bleeding Risk Management
- For patients at high risk of postoperative bleeding, delay enoxaparin administration for at least 24 hours 1
- If using spinal/epidural anesthesia, avoid enoxaparin administration within 10-12 hours before the procedure to reduce risk of spinal hematoma 3
Important Cautions
- Enoxaparin is not recommended for thromboprophylaxis in patients with prosthetic heart valves 1
- For patients with renal impairment (CrCl <30 mL/min), reduce prophylactic dose to 30 mg SC daily 3
- For obese patients (BMI >30 kg/m²), consider intermediate dosing (40 mg SC q12h) or weight-based dosing 3